当前位置: 首页 >> 检索结果
共有 1920 条符合本次的查询结果, 用时 1.7486656 秒

41. Tumour-intrinsic alterations and stromal matrix remodelling promote Wnt-niche independence during diffuse-type gastric cancer progression.

作者: Lars J S Kemp.;Jooske L Monster.;Colin S Wood.;Martijn Moers.;Marjolein J Vliem.;Antoine A Khalil.;Nigel B Jamieson.;Lodewijk A A Brosens.;Liudmila L Kodach.;Jolanda M van Dieren.;Tanya M Bisseling.;Rachel S van der Post.;Martijn Gloerich.
来源: Gut. 2025年
Development of diffuse-type gastric cancer (DGC) starts with intramucosal lesions that are primarily composed of differentiated, non-proliferative signet ring cells (SRCs). These indolent lesions can advance into highly proliferative and metastatic tumours, which requires suppression of DGC cell differentiation.

42. ETV5-S100A9 feed-forward loop connecting HCC and MDSCs to shape the immunosuppressive tumour microenvironment.

作者: Carmen Chak-Lui Wong.;Chun Ming Wong.
来源: Gut. 2025年

43. Introducing 'borderline observable' intraductal papillary mucinous neoplasms: between pancreatic cancer risk and discontinuation of extended surveillance.

作者: Giampaolo Perri.;Giovanni Marchegiani.
来源: Gut. 2025年

44. Endoscopic resection after downstaging of oesophageal carcinoma by neoadjuvant chemoimmunotherapy: - a new multimodal concept?

作者: Mingyan Cai.;Baohui Song.;Dongli He.;Chen Xu.;Rongkui Luo.;Yang Qian.;Sikei Kam.;Xucheng Huo.;Jian Wang.;Michael Vieth.;Yunshi Zhong.
来源: Gut. 2025年

45. Combining faecal haemoglobin, iron deficiency anaemia status and age can improve colorectal cancer risk prediction in patients attending primary care with bowel symptoms: a retrospective observational study.

作者: Jayne Digby.;Jennifer Nobes.;Judith A Strachan.;Rebecca McCann.;Christopher Hall.;Callum G Fraser.;Craig Mowat.
来源: Gut. 2025年
In primary care, National Institute for Health and Care Excellence suspected cancer guidelines recommend measuring faecal haemoglobin (f-Hb) if colorectal cancer (CRC) is suspected, with a referral threshold of ≥10 µg Hb/g faeces defining a 3% risk, but most have a normal colonoscopy.

46. 24-Nor-ursodeoxycholic acid: a novel treatment targeting T-cell-mediated immune dysregulation in primary sclerosing cholangitis and beyond.

作者: Likai Tan.;William Ka Kei Wu.
来源: Gut. 2025年

47. Stressed hepatocyte sustains alcohol-associated hepatitis progression by producing leukocyte cell-derived chemotaxin 2.

作者: Honghai Xu.;Zihao Wu.;Jiangfeng Qin.;Xutong Li.;Feng Xu.;Wei Wang.;Hui Zhang.;HeHe Yin.;Shiwei Zhu.;Wenzhe Zhang.;Yuanru Yang.;Yuanyuan Wei.;Long Gao.;Jiatao Liu.;Yufeng Gao.;Ming-Hua Zheng.;Haoxiong Zhou.;Tingting Qi.;Jinjun Chen.;Yanhang Gao.;Li Zuo.;Jiong Chen.;Suthat Liangpunsakul.;Jiabin Li.;Hua Wang.
来源: Gut. 2025年
Neutrophil infiltration and hepatocyte damage are indispensable hallmarks in alcohol-associated hepatitis (AH), yet the underlying crosstalk between neutrophils and hepatocytes and its role in AH pathogenesis remain unclear.

48. Dietary whey protein protects against Crohn's disease by orchestrating cross-kingdom interaction between the gut phageome and bacteriome.

作者: Runping Su.;Weijie Wen.;Yufeng Jin.;Zhirui Cao.;Zhiyang Feng.;Jie Chen.;Yu Lu.;Guicheng Zhou.;Chao Dong.;Shanshan Gao.;Xue Li.;Hu Zhang.;Kang Chao.;Ping Lan.;Xiaojian Wu.;Anna Philips.;Kun Li.;Xiang Gao.;Fen Zhang.;Tao Zuo.
来源: Gut. 2025年
The gut microbiome and diet are important factors in the pathogenesis and management of Crohn's disease (CD). However, the role of the gut phageome under dietary influences is unknown.

49. Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and paracrine signalling.

作者: Xugang Sun.;Wenrun Cai.;Haorui Li.;Chuntao Gao.;Xi Ma.;Yu Guo.;Danqi Fu.;Di Xiao.;Zhaoyu Zhang.;Yifei Wang.;Shengyu Yang.;Yukuan Feng.;Tiansuo Zhao.;Jihui Hao.
来源: Gut. 2025年
Cancer-associated fibroblasts (CAFs) are highly heterogeneous in the progression of pancreatic ductal adenocarcinoma (PDAC) and vasculogenic mimicry (VM) refers to a phenomenon in which cancer cells adopt endothelial-like characteristics.

50. Longitudinal paired liver biopsies and transcriptome profiling in alcohol-associated hepatitis reveal dynamic changes in cellular senescence.

作者: Daniel Rodrigo-Torres.;Alastair M Kilpatrick.;Sofia Ferreira-Gonzalez.;Rhona E Aird.;Stephen Rahul Atkinson.;Victoria L Gadd.;Tak Yung Man.;Luke D Tyson.;Gopal Krishna R Dhondalay.;Nikhil Vergis.;Gavin E Arteel.;Mark R Thursz.;Laura Martinez-Gili.;Stuart J Forbes.
来源: Gut. 2025年
Alcohol-associated hepatitis (AH) is an acute form of alcohol-related liver disease (ALD) with high mortality rate. AH is histologically characterised by cellular processes, including steatosis, inflammation and cell death. Apoptosis is the most studied form of cell death in AH; however, the role of cellular senescence, another response to cellular injury, in AH is unknown. Here, we explore the mechanisms of ALD pathophysiology and describe the role of senescence in AH.

51. Rectal non-steroidal anti-inflammatory drugs and post-ERCP pancreatitis: it is time for the next chapter in prophylaxis.

作者: Gregory A Coté.
来源: Gut. 2025年

52. Diagnostic efficacy of an extracellular vesicle-derived lncRNA-based liquid biopsy signature for the early detection of early-onset gastric cancer.

作者: Xin Guo.;Weidong Wang.;Xin Cheng.;Qiying Song.;Xinxin Wang.;Jiangpeng Wei.;Shenhui Xu.;Xiaohui Lv.;Gang Ji.
来源: Gut. 2025年
Early-onset gastric cancer (EOGC) is a lethal malignancy. It differs from late-onset gastric cancer (LOGC) in clinical and molecular characteristics. The current strategies for EOGC detection have certain limitations in diagnostic performance due to the rising trend in EOGC.

53. Rectal diclofenac versus indomethacin for prevention of post-ERCP pancreatitis (DIPPP): a multicentre, double-blind, randomised, controlled trial.

作者: Xiaoyu Kang.;Mingxing Xia.;Jun Wang.;Xiangping Wang.;Hui Luo.;Wenhao Qin.;Zirong Liang.;Gang Zhao.;Longbao Yang.;Hao Sun.;Jie Tao.;Bo Ning.;Li Zhong.;Rongchun Zhang.;Xuyuan Ma.;Jianghai Zhao.;Laifu Yue.;Haifeng Jin.;Chenxi Kang.;Gui Ren.;Shuhui Liang.;Haiying Wang.;Ling Wang.;Yongzhan Nie.;Kaichun Wu.;Dai-Ming Fan.;Yanglin Pan.
来源: Gut. 2025年
Recent meta-analyses suggested diclofenac may be superior to indomethacin in preventing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). The aim of our study was to compare the efficacy of 100 mg rectal indomethacin versus diclofenac on PEP incidences.

54. Global prevalence of ultra-short coeliac disease (USCD): the first systematic review and meta-analysis.

作者: Sahand Karimzadhagh.;Behrooz Ahmadi.;Meysam Olfatifar.;Hamidreza Houri.;Nastaran Asri.;Mohammad Rostami-Nejad.;David S Sanders.
来源: Gut. 2025年

55. GPR171 restrains intestinal inflammation by suppressing FABP5-mediated Th17 cell differentiation and lipid metabolism.

作者: Fushun Kou.;Xiao-Yu Li.;Zhongsheng Feng.;Jinghan Hua.;Xiaohan Wu.;Han Gao.;Jian Lin.;Dengfeng Kang.;Ai Li.;Junxiang Li.;Yao Ding.;Ting Ban.;Qing Zhang.;Zhanju Liu.
来源: Gut. 2025年
GPR171 suppresses T cell immune responses involved in antitumour immunity, while its role in inflammatory bowel disease (IBD) pathogenesis remains unclear.

56. British Society of Gastroenterology practice guidance on the management of acute and chronic gastrointestinal symptoms and complications as a result of treatment for cancer.

作者: Jervoise Andreyev.;Richard Adams.;Jan Bornschein.;Mark Chapman.;Dave Chuter.;Sally Darnborough.;Andrew Davies.;Fiona Dignan.;Clare Donnellan.;Darren Fernandes.;Robert Flavel.;Georgina Giebner.;Alexandra Gilbert.;Fiona Huddy.;Mohid Shakil S Khan.;Pauline Leonard.;Shameer Mehta.;Ollie Minton.;Christine Norton.;Louise Payton.;Gill McGuire.;D Mark Pritchard.;Claire Taylor.;Susan Vyoral.;Ana Wilson.;Linda Wedlake.
来源: Gut. 2025年
Survival rates after a diagnosis of cancer are improving. Poorly managed gastrointestinal (GI) side effects can interfere with delivery of curative cancer treatment. Long-term physical side effects of cancer therapy impinge on quality of life in up to 25% of those treated for cancer, and GI side effects are the most common and troublesome.

57. Vasomics of the liver.

作者: Chengyan Wang.;Eric Felli.;Jonathan Andrew Fallowfield.;Christoph Frank Dietrich.;Don Rockey.;Jürgen Hennig.;Gao-Jun Teng.;Jordi Gracia-Sancho.;Xiaolong Qi.
来源: Gut. 2025年
Chronic liver disease is a cluster of disorders associated with complex haemodynamic alterations, which is characterised by structural and functional disruptions of the intrahepatic and extrahepatic vasculature. 'Vasomics' is an emerging omics discipline that comprehensively analyses and models the vascular system by integrating pathophysiology of disease, biomechanics, medical imaging, computational science and artificial intelligence. Vasomics is further typified by its multidimensional, multiscale and high-throughput nature, which depends on the rapid and robust extraction of well-defined vascular phenotypes with clear clinical and/or biological interpretability. By leveraging multimodality medical imaging techniques, vascular functional assessments, pathological image evaluation, and related computational methods, integrated vasomics provides a deeper understanding of the associations between the vascular system and disease. This in turn reveals the crucial role of the vascular system in disease occurrence, progression and treatment responses, thereby supporting precision medicine approaches. Pathological vascular features have already demonstrated their key role in different clinical scenarios. Despite this, vasomics is yet to be widely recognised. Therefore, we furnished a comprehensive definition of vasomics providing a classification of existing hepatic vascular phenotypes into the following categories: anatomical, biomechanical, biochemical, pathophysiological and composite.

58. Margin thermal ablation eliminates size as a risk factor for recurrence after piecemeal endoscopic mucosal resection of large non-pedunculated colorectal polyps.

作者: Julia L Gauci.;Francesco Vito Mandarino.;Clarence Kerrison.;Anthony M Whitfield.;Timothy O'Sullivan.;Sunil Gupta.;Brian Lam.;Varan Perananthan.;Oliver Cronin.;Eric Y Lee.;Steven J Williams.;Nicholas Burgess.;Michael J Bourke.
来源: Gut. 2025年74卷5期752-760页
Lesion size is an independent risk factor for recurrence following endoscopic mucosal resection of large (≥20 mm) non-pedunculated colorectal polyps. Post-resection margin thermal ablation (MTA) reduces the risk of recurrence. Its impact on the uncommon larger (≥40 mm) lesions is unknown.

59. 24-Nor-ursodeoxycholic acid improves intestinal inflammation by targeting TH17 pathogenicity and transdifferentiation.

作者: Ci Zhu.;Nicole Boucheron.;Osamah Al-Rubaye.;Brian K Chung.;Liv Wenche Thorbjørnsen.;Thomas Köcher.;Michael Schuster.;Thierry Claudel.;Emina Halilbasic.;Victoria Kunczer.;Fanziska Muscate.;Lois L Cavanagh.;Darina Waltenberger.;Alexander Lercher.;Anna Ohradanova-Repic.;Philipp Schatzlmaier.;Tatjana Stojakovic.;Hubert Scharnagl.;Andreas Bergthaler.;Hannes Stockinger.;Samuel Huber.;Christoph Bock.;Lukas Kenner.;Tom H Karlsen.;Wilfried Ellmeier.;Michael Trauner.
来源: Gut. 2025年
24-Nor-ursodeoxycholic acid (NorUDCA) is a novel therapeutic bile acid for treating immune-mediated cholestatic liver diseases, such as primary sclerosing cholangitis (PSC).

60. Bioprinting functional hepatocyte organoids derived from human chemically induced pluripotent stem cells to treat liver failure.

作者: Guangya Li.;Jianyu He.;Jihang Shi.;Xinyi Li.;Lulu Liu.;Xinlan Ge.;Wenhan Chen.;Jun Jia.;Jinlin Wang.;Ming Yin.;Yasuyuki Sakai.;Wei Sun.;Hongkui Deng.;Yuan Pang.
来源: Gut. 2025年
To treat liver failure, three-dimensional (3D) bioprinting is a promising technology used to construct hepatic tissue models. However, current research on bioprinting of hepatic tissue models primarily relies on conventional single-cell-based bioprinting, where individual functional hepatocytes are dispersed and isolated within hydrogels, leading to insufficient treatment outcomes due to inadequate cell functionality.
共有 1920 条符合本次的查询结果, 用时 1.7486656 秒